STING1 and neoplasm: The fact that chemotherapeutics-killed tumor cells can potentially transport tumor DNA to APCs to activate the STING pathway creates great opportunities to promote antitumor T cell immunity, but chemotherapeutics suffered from poor targeted tumor cell killing, making it difficult to transfer tumor DNA, as well as tumor antigens, to APCs.